DMG-PEG2000-NH2: NH2-PEG Derivative for LNP Drug Delivery

Executive Summary: DMG-PEG2000-NH2 (SKU: M2006) is a linear polyethylene glycol derivative functionalized with a terminal primary amine, enabling efficient amide bond formation with biomolecules bearing carboxyl groups. This reagent, supplied by APExBIO, is widely used in constructing lipid-based drug delivery systems such as liposomes and LNPs, particularly for nucleic acid (siRNA) encapsulation (product page). The product is characterized by a molecular weight of 2528, high solubility in water, ethanol, and DMSO, and a purity greater than 90%. Its chemical properties allow for enhanced solubility, stability, and biocompatibility of conjugated cargo, supporting reproducible pharmaceutical and biochemical workflows (internal link). Quality control data, including COA and MSDS, are provided to ensure batch-to-batch consistency. These attributes make DMG-PEG2000-NH2 a preferred linker for advanced drug delivery and bioconjugation strategies (Chen et al. 2021).

Biological Rationale

Lipid nanoparticles (LNPs) and liposomes are established vehicles for the delivery of therapeutic agents, including siRNA, mRNA, and small molecule drugs. The stability and performance of these delivery systems depend on the presence of hydrophilic, biocompatible linkers to prevent aggregation, prolong circulation, and facilitate surface modification (Chen et al. 2021). DMG-PEG2000-NH2, a polyethylene glycol amine linker, introduces a flexible, hydrophilic spacer that improves solubility and reduces immunogenicity. The primary amine group enables covalent conjugation with carboxyl-containing biomolecules via amide bond formation. PEGylation with DMG-PEG2000-NH2 enhances pharmacokinetics by reducing opsonization and renal clearance, thus increasing the efficacy of encapsulated agents (Bridging Molecular Design). This product is especially critical for formulating next-generation LNPs used in nucleic acid therapeutics.

Mechanism of Action of DMG-PEG2000-NH2

DMG-PEG2000-NH2 contains a dimyristoylglycerol (DMG) lipid anchor covalently linked to a 2000 Da polyethylene glycol (PEG) chain terminated with a primary amine (-NH₂). The DMG anchor integrates into lipid bilayers, while the PEG chain extends into the aqueous environment, providing steric stabilization. The terminal NH₂ group reacts readily with carboxyl groups on proteins, peptides, or other molecules through carbodiimide- or NHS-mediated coupling, forming amide bonds (product page). This bioconjugation increases the hydrophilicity and stability of the attached molecules and enables site-specific modification of nanoparticle surfaces. The PEG shell also shields the nanoparticle from protein adsorption and immune recognition, prolonging circulation half-life and reducing off-target effects (Mechanistic Advances).

Evidence & Benchmarks

• DMG-PEG2000-NH2 exhibits water solubility >25.3 mg/mL, ethanol solubility >52 mg/mL, and DMSO solubility >51.6 mg/mL under ambient conditions (APExBIO).
• Amide bond formation with carboxyl-containing biomolecules is robust under EDC/NHS activation, with yields >85% at pH 7.0–8.0 (Optimizing Liposomal Drug Delivery Linker).
• PEGylation with DMG-PEG2000-NH2 increases LNP circulation time 2–5 fold in rodent models compared to non-PEGylated controls (Chen et al. 2021).
• Formulations using DMG-PEG2000-NH2 demonstrate encapsulation efficiencies for siRNA >90% under standard microfluidic mixing protocols (Bridging Molecular Design).
• The primary amine group remains reactive after storage at -20°C for up to 12 months, with <5% loss in coupling efficiency (APExBIO).

Applications, Limits & Misconceptions

DMG-PEG2000-NH2 is a versatile bioconjugation reagent for:

• Lipid nanoparticle (LNP) formulation for siRNA, mRNA, and small molecule delivery.
• Liposomal surface modification to enhance stability and targeting.
• Covalent conjugation of proteins, peptides, or antibodies to nanoparticles via amide bond formation.
• PEGylation to improve solubility and biocompatibility of therapeutic agents.

This article provides updated mechanistic and parameter-specific guidance, extending the practical focus of Optimizing Liposomal Drug Delivery Linker and clarifying integration steps beyond the general overviews in Biocompatible PEGylation Linker and Bridging Molecular Design.

Common Pitfalls or Misconceptions

• Not all carboxyl-containing biomolecules are equally reactive: Steric hindrance or improper pH can reduce coupling efficiency.
• Long-term storage of dissolved DMG-PEG2000-NH2 (>1 week) can lead to amine oxidation: Always prepare fresh solutions for critical applications.
• Excessive PEGylation may hinder receptor-mediated uptake: Optimize PEG density according to application.
• DMG-PEG2000-NH2 is not suitable for direct conjugation with aldehyde or thiol groups: Use appropriate functionalized PEG derivatives for these chemistries.
• PEGylation cannot fully prevent immune clearance in all models: Complementary strategies may be required for stealth delivery in certain biological systems.

Workflow Integration & Parameters

For bioconjugation workflows, DMG-PEG2000-NH2 is typically dissolved in water, ethanol, or DMSO at recommended concentrations. Coupling reactions with carboxyl-containing biomolecules are performed using EDC/NHS activation at pH 7.0–8.0, 20–25°C, for 2–4 hours. Excess reagent is removed by dialysis or ultrafiltration. For LNP or liposome formulation, DMG-PEG2000-NH2 is mixed with other lipid components in organic solvent, dried to a film, and hydrated in buffer before extrusion or microfluidic mixing. The recommended storage temperature is -20°C for the solid form; avoid repeated freeze-thaw cycles. Quality control includes mass spectrometry and HPLC to confirm product identity and purity. For detailed workflow troubleshooting, refer to scenario-driven guidance in Enhancing Cell Assays with DMG-PEG2000-NH2, which this article extends by providing updated storage and coupling kinetics data.

Conclusion & Outlook

DMG-PEG2000-NH2 (M2006, APExBIO) remains a benchmark NH2-PEG derivative for constructing advanced lipid-based drug delivery systems. Its high purity, robust amine reactivity, and favorable solubility profile make it suitable for reproducible bioconjugation and LNP workflows. Ongoing research continues to expand its use in precision nanomedicine and targeted delivery applications. For ordering and technical details, visit the DMG-PEG2000-NH2 product page.